Bamco Inc. NY acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 427,888 shares of the medical device company's stock, valued at approximately $30,684,000. Bamco Inc. NY owned about 0.22% of Cooper Companies as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Heartland Advisors Inc. bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in shares of Cooper Companies by 6.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company's stock worth $34,224,000 after purchasing an additional 23,896 shares during the period. Tocqueville Asset Management L.P. acquired a new position in Cooper Companies in the 2nd quarter valued at approximately $1,502,000. Swedbank AB raised its stake in shares of Cooper Companies by 18.8% in the fourth quarter. Swedbank AB now owns 1,074,029 shares of the medical device company's stock valued at $88,027,000 after purchasing an additional 170,000 shares in the last quarter. Finally, Capital International Inc. CA lifted its holdings in shares of Cooper Companies by 22.9% during the 4th quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company's stock worth $9,688,000 after acquiring an additional 22,054 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several analysts recently commented on COO shares. Needham & Company LLC decreased their price target on Cooper Companies from $101.00 to $86.00 and set a "buy" rating on the stock in a research note on Friday, June 5th. Mizuho set a $85.00 target price on Cooper Companies and gave the stock an "outperform" rating in a report on Thursday, June 4th. BNP Paribas Exane decreased their price target on Cooper Companies from $95.00 to $92.00 and set an "outperform" rating on the stock in a research report on Monday, June 8th. Citigroup reaffirmed a "neutral" rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Finally, JPMorgan Chase & Co. cut their price objective on Cooper Companies from $80.00 to $71.00 and set a "neutral" rating for the company in a research report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, Cooper Companies has an average rating of "Hold" and a consensus price target of $81.64.
Get Our Latest Analysis on COO
Cooper Companies Stock Performance
COO stock opened at $72.68 on Thursday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a market cap of $14.17 billion, a P/E ratio of 61.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.83. The business's fifty day moving average is $72.36 and its 200-day moving average is $70.96.
Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. During the same period in the previous year, the company earned $0.96 EPS. The company's revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current year.
Cooper Companies Profile
(
Free Report)
Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
